Back

Pregnancy, in vitro fertilization and cardiovascular outcomes in women with hereditary thoracic aortic diseases compared to controls: a retrospective register-based matched case-control study

30 August 2026 (16:21 - 16:33)
Organised by: Logo
Congress Presentation Part of: High-risk pregnancy and maternal cardiovascular vulnerability: disparities, prediction, and prevention Pregnancy and Cardiovascular Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Joanna Hlebowicz

Skane University Hospital, Lund (Sweden)

4 More presentations in this session

Presentation thumbnail
Association between aspirin use before 16 weeks of gestation and early postpartum cardiometabolic risk: an electronic health record–based study
Miss J. Li (Tianjin, CN)
Abstract
Presentation thumbnail
Food insecurity increases risk for peripartum cardiomyopathy and early presentation
Doctor K. Sompel (Aurora, US)
Abstract
Presentation thumbnail
Racial disparities in severe maternal morbidity among peripartum cardiomyopathy deliveries
Mr I. Bolad (Indiana, US)
Abstract
Presentation thumbnail
Long-term cardiovascular morbidity and mortality after maternal heart failure: a nationwide population-based cohort study
Doctor C. Kihlborg (Stockholm, SE)
Abstract

Access the full session

Session thumbnail
High-risk pregnancy and maternal cardiovascular vulnerability: disparities, prediction, and prevention

The Event

Event poster

ESC Congress 2026

30 August 2026 16:21 CET
You may be interested in
thumbnail
Congress Presentation
Hypertensive disorders of pregnancy in women with structural heart disease: data from the ESC EORP Registry of Pregnancy and Cardiac disease (ROPAC)
29 August 2021
thumbnail
Congress Presentation
What are the diseases we’re looking for and importance of the genetics
11 May 2023
thumbnail
Congress Presentation
Impact of reproductive factors on major cardiovascular disease risk in women: a mendelian randomization study.
28 August 2022
thumbnail
Congress Presentation
A focus on pregnancy course and outcomes of women with zero-fluoroscopy catheter ablation during gestation: a 2-year follow-up study
17 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources